[Prostatic Artery Embolization (PAE) - Endo-vascular Treatment of Lower Urinary Tract Symptoms Presumed Secondary to Benign Prostatic Obstruction].

IF 0.2 Q4 MEDICINE, GENERAL & INTERNAL THERAPEUTISCHE UMSCHAU Pub Date : 2023-04-01 DOI:10.1024/0040-5930/a001424
Dominik Abt, Sandro Lütolf, Nicola Giudici
{"title":"[Prostatic Artery Embolization (PAE) - Endo-vascular Treatment of Lower Urinary Tract Symptoms Presumed Secondary to Benign Prostatic Obstruction].","authors":"Dominik Abt,&nbsp;Sandro Lütolf,&nbsp;Nicola Giudici","doi":"10.1024/0040-5930/a001424","DOIUrl":null,"url":null,"abstract":"<p><p>Prostatic Artery Embolization (PAE) - Endo-vascular Treatment of Lower Urinary Tract Symptoms Presumed Secondary to Benign Prostatic Obstruction <b>Abstract:</b> Based on the available evidence on efficacy and safety in the short to midterm, Prostatic Artery Embolization (PAE) is now endorsed by international evidence-based guidelines as a treatment of lower urinary tract symptoms presumed secondary to benign prostatic obstruction (LUTS/BPO) for selected patients. As PAE has a unique treatment approach (i.e., endovascular instead of transurethral), its profile and ideal application differ clearly from other treatments of LUTS/BPO, which must be considered for patient selection. Performance in local anesthesia with ongoing anticoagulation and no upper prostate size limitation represent advantages of the technique. Limited availability, an inferior relief of obstruction associated with higher retreatment rates and inferior outcomes in small prostates represent disadvantages. This should be considered for patient selection and counselling.</p>","PeriodicalId":44874,"journal":{"name":"THERAPEUTISCHE UMSCHAU","volume":"80 3","pages":"123-126"},"PeriodicalIF":0.2000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"THERAPEUTISCHE UMSCHAU","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1024/0040-5930/a001424","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Prostatic Artery Embolization (PAE) - Endo-vascular Treatment of Lower Urinary Tract Symptoms Presumed Secondary to Benign Prostatic Obstruction Abstract: Based on the available evidence on efficacy and safety in the short to midterm, Prostatic Artery Embolization (PAE) is now endorsed by international evidence-based guidelines as a treatment of lower urinary tract symptoms presumed secondary to benign prostatic obstruction (LUTS/BPO) for selected patients. As PAE has a unique treatment approach (i.e., endovascular instead of transurethral), its profile and ideal application differ clearly from other treatments of LUTS/BPO, which must be considered for patient selection. Performance in local anesthesia with ongoing anticoagulation and no upper prostate size limitation represent advantages of the technique. Limited availability, an inferior relief of obstruction associated with higher retreatment rates and inferior outcomes in small prostates represent disadvantages. This should be considered for patient selection and counselling.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[前列腺动脉栓塞(PAE) -血管内治疗下尿路症状继发于良性前列腺梗阻]。
摘要:基于现有的中短期疗效和安全性的证据,前列腺动脉栓塞(PAE)现在被国际循证指南认可为治疗被认为继发于良性前列腺梗阻(LUTS/BPO)的特定患者的下尿路症状。由于PAE具有独特的治疗方式(即血管内而非经尿道),其特点和理想应用与其他LUTS/BPO治疗有明显的不同,在患者选择时必须考虑到这一点。在持续抗凝的局部麻醉下的表现和没有上前列腺大小的限制代表了该技术的优势。可用性有限,小前列腺的梗阻缓解较差,再治疗率较高,预后较差,这是缺点。在患者选择和咨询时应考虑到这一点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
THERAPEUTISCHE UMSCHAU
THERAPEUTISCHE UMSCHAU MEDICINE, GENERAL & INTERNAL-
CiteScore
0.50
自引率
0.00%
发文量
75
期刊介绍: Monat für Monat ein aktuelles Thema der praktischen Medizin - als Sammlung ein hochaktuelles Nachschlagewerk.
期刊最新文献
[Calcium pyrophosphate deposition (CPPD) disease - more than just "pseudogout"]. [Gout - clinical presentation]. [Gout and Nutrition]. [Imaging in crystal arthropathies]. [Therapy of gout in 2024].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1